PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX-100 progresses to next cohort in basket clinical study, page-5

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Great news.
    Escalation continues to be within the safety spectrum. Early efficacy signs on small number of volunteers is also handy.
    Well done PTX thus far.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.